Preclinical and clinical evaluation of 5-fluorouracil biochemical modulation with folinic acid and hydroxyurea for patients with colorectal carcinoma. | Cancer;76(8): 1330-5, 1995 Oct 15. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Preclinical and clinical evaluation of 5-fluorouracil biochemical modulation with folinic acid and hydroxyurea for patients with colorectal carcinoma.

Matei, D; Hagag, N; Madajewicz, S; Chowhan, N; Hentschel, P; Avvento, L; Burns, P; Fiore, J; Lipera, W; Zarrabi, H.

Affiliation

Matei D; Division of Medical Oncology, SUNY at Stony Brook, USA.

Cancer ; 76(8): 1330-5, 1995 Oct 15.

Article in En | MEDLINE | ID: mdl-8620405

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Leucovorin / Fluorouracil / Hydroxyurea / Immunologic Factors / Antimetabolites, Antineoplastic Type of study: Clinical_trials Limits: Humans Language: En Journal: Cancer Year: 1995 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Leucovorin / Fluorouracil / Hydroxyurea / Immunologic Factors / Antimetabolites, Antineoplastic Type of study: Clinical_trials Limits: Humans Language: En Journal: Cancer Year: 1995 Document type: Article Affiliation country: Country of publication: